Oklahoma Medical Research Foundation (OMRF)

Discoveries that make a difference.

Home - OMRF News - Archives for chemo

chemo

Q BioMed Inc. finalizes license agreement with OMRF, RGCB

QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.